Home > Products > IL17 & TNF
> Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scFv4-Ig)
Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-175)
Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-IL17 scFv is fused to the CH1 domain of a heavy chain and another anti-TNF scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Rheumatoid arthritis (RA); Plaque psoriasis therapy.
There are currently no customer reviews or questions for Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (scFv4-Ig) (FVTIG-175). Click the button below to contact us or submit your feedback about this product.